Most cited papers from Ospedale Santa Maria

Ospedale Santa Maria

What are the most cited papers from Ospedale Santa Maria?

The most cited paper from Ospedale Santa Maria is "Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden" (Matthew David Hellmann et al., 2018), with 3,185 citations. Next come "Functional impact of global rare copy number variation in autism spectrum disorders" (2,073) and "Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity" (2,020).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 61 papers. Every paper with more than 289 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden Matthew David Hellmann et al. · New England Journal of Medicine Open access	16 Apr 2018	3,185
2	Functional impact of global rare copy number variation in autism spectrum disorders Dalila Pinto et al. · Nature Open access177 authors	8 Jun 2010	2,073
3	Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity Luc M. Van Bortel, Stéphane Laurent, Pierre Boutouyrie et al. · Journal of Hypertension Open access	21 Jan 2012	2,020
4	The pivotal link between ACE2 deficiency and SARS-CoV-2 infection Paolo Verdecchia, Claudio Cavallini, Antonio Spanevello et al. · European Journal of Internal Medicine Open access	20 Apr 2020	1,295
5	Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer Fotios Loupakis, Chiara Cremolini, Gianluca Masi et al. · New England Journal of Medicine Open access	22 Oct 2014	1,097
6	Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy Ovidio De Filippo et al. · New England Journal of Medicine Open access	28 Apr 2020	1,058
7	BRAF Mutations in Hairy-Cell Leukemia Enrico Tiacci et al. · New England Journal of Medicine Open access	11 Jun 2011	1,029
8	Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial Vincent A. Miller, Vera Hirsh, Jacques L. Cadranel et al. · The Lancet Oncology	25 Mar 2012	961
9	Oxidative stress and Parkinson’s disease Javier Blesa, Inés Trigo‐Damas, Ana Quiroga‐Varela et al. · Frontiers in Neuroanatomy Open access	8 Jul 2015	897
10	Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy Jose Angel Obeso et al. · Movement Disorders Open access	Sep 2017	871
11	Direct and indirect pathways of basal ganglia: a critical reappraisal Paolo Calabresi, Barbara Picconi, Alessandro Tozzi et al. · Nature Neuroscience	28 Jul 2014	855
12	Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study Michèle Cavo et al. · The Lancet	Dec 2010	825
13	The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients Paolo Prandoni, Franco Noventa, Angelo Ghirarduzzi et al. · Haematologica Open access	Feb 2007	778
14	EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies Manuel Ramos‐Casals et al. · Annals of the Rheumatic Diseases Open access	31 Oct 2019	736
15	Pregnancy complications in women with polycystic ovary syndrome Stefano Palomba, Marlieke A. de Wilde, Angela Immacolata Falbo et al. · Human Reproduction Update Open access	27 Jun 2015	723
16	Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer Hossein Borghaei et al. · Journal of Clinical Oncology Open access	15 Jan 2021	683
17	High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults Paolo Pedrazzoli, Jonathan A. Ledermann, Jean‐Pierre Lotz et al. · Annals of Oncology Open access	17 Mar 2006	655
18	Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Martin Früh, Dirk De Ruysscher, Sanjay Popat et al. · Annals of Oncology Open access	28 Jun 2013	619
19	Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’ 1 Andrés J.M. Ferreri et al. · British Journal of Haematology Open access	Oct 2004	616
20	PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients Armida D’Incecco, Mariacarla Andreozzi, Vienna Ludovini et al. · British Journal of Cancer Open access	28 Oct 2014	611
21	A genome-wide scan for common alleles affecting risk for autism Richard Anney et al. · Human Molecular Genetics Open access166 authors	27 Jul 2010	594
22	Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment Alessandra Fabi, Ravi Bhargava, Sonia Fatigoni et al. · Annals of Oncology Open access	12 Mar 2020	578
23	Interdisciplinary Expert Consensus Document on Management of Type B Aortic Dissection Rossella Fattori, Piergiorgio Cao, Paola De Rango et al. · Journal of the American College of Cardiology Open access	Apr 2013	494
24	2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules Enrico Papini, Hervé Monpeyssen, Andrea Frasoldati et al. · European Thyroid Journal Open access	8 Jun 2020	472
25	Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial Carlo Di Mario, Dariusz Dudek, Federico Piscione et al. · The Lancet	Feb 2008	439
26	Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial Paolo Verdecchia, Jan A. Staessen, Fabio Angeli et al. · The Lancet Open access	Aug 2009	437
27	A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable Alessio Cortellini et al. · Journal for ImmunoTherapy of Cancer Open access	27 Feb 2019	426
28	Randomized Trial of Fenretinide to Prevent Second Breast Malignancy in Women With Early Breast Cancer Umberto Veronesi et al. · JNCI Journal of the National Cancer Institute	3 Nov 1999	421
29	Complications of Central Neck Dissection in Patients with Papillary Thyroid Carcinoma: Results of a Study on 1087 Patients and Review of the Literature Davide Giordano, Roberto Valcavi, Geoffrey B. Thompson et al. · Thyroid	24 Jul 2012	417
30	Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients Antonio Curti, Loredana Ruggeri, Alessandra D’Addio et al. · Blood Open access	27 Jul 2011	405
31	Extended Oral Anticoagulant Therapy after a First Episode of Pulmonary Embolism Giancarlo Agnelli, Paolo Prandoni, Cecilia Becattini et al. · Annals of Internal Medicine	Jul 2003	400
32	HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse Massimo F. Martelli, Mauro Di Ianni, Loredana Ruggeri et al. · Blood	13 Jun 2014	400
33	Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels Patrizia Bonadonna, Omar Perbellini, Giovanni Passalacqua et al. · Journal of Allergy and Clinical Immunology Open access	10 Jan 2009	396
34	Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study Michèle Cavo et al. · The Lancet Haematology Open access	30 Apr 2020	387
35	Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap Paolo Calabresi, Massimiliano Di Filippo, Veronica Ghiglieri et al. · The Lancet Neurology Open access	Oct 2010	387
36	Mechanism of Syncope in Patients With Isolated Syncope and in Patients With Tilt-Positive Syncope Angel Moya, Michele Brignole, Carlo Menozzi et al. · Circulation Open access	11 Sep 2001	380
37	Individual common variants exert weak effects on the risk for autism spectrum disorders Richard Anney et al. · Human Molecular Genetics Open access137 authors	26 Jul 2012	378
38	Diabetes mellitus in schizophrenic patients Sukdeb Mukherjee, Paolo Decina, Vittorio Bocola et al. · Comprehensive Psychiatry	1996	371
39	Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography Maurizio Valentino Infante et al. · American Journal of Respiratory and Critical Care Medicine	11 Mar 2015	371
40	Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis Biagio Ricciuti, Carlo Genova, Andrea De Giglio et al. · Journal of Cancer Research and Clinical Oncology Open access	Dec 2018	366
41	Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia Enrico Tiacci et al. · New England Journal of Medicine Open access	10 Sep 2015	349
42	Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries Diana Aguiar de Sousa, Rascha von Martial, Sònia Abilleira et al. · European Stroke Journal Open access	20 Jul 2018	348
43	Dissociation of the pathways mediating ipsilateral and contralateral motor‐evoked potentials in human hand and arm muscles Ulf Ziemann, Kenji Ishii, Alessandra Borgheresi et al. · The Journal of Physiology Open access	Aug 1999	348
44	Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts Alberto J. Espay, Francesca Morgante, Aristide Merola et al. · Annals of Neurology Open access	24 Oct 2018	346
45	Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial Chiara Cremolini et al. · The Lancet Oncology Open access	9 Mar 2020	335
46	Mood and behavioural effects of subthalamic stimulation in Parkinson's disease Anna Castrioto, Eugénie Lhommée, Elena Moro et al. · The Lancet Neurology Open access	17 Feb 2014	334
47	Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study Cristina Bezzio et al. · Gut Open access	30 Apr 2020	332
48	Assessment of a HER2 scoring system for colorectal cancer: results from a validation study Emanuele Valtorta et al. · Modern Pathology Open access	9 Oct 2015	323
49	Neuroimaging Findings in Acute Wernicke's Encephalopathy: Review of the Literature Giulio Zuccoli, Nicolò Pipitone · American Journal of Roentgenology	20 Jan 2009	319
50	Standardization of terminology in dermoscopy/dermatoscopy: Results of the third consensus conference of the International Society of Dermoscopy Harald Kittler et al. · Journal of the American Academy of Dermatology Open access	19 Feb 2016	318

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.